Advertisement
Home Tags Diabetes: Type I

Tag: Diabetes: Type I

For patients with type 1 diabetes

Bidirectional Association for Depression, Dysglycemia in T1DM

Depression increases risk of dysglycemia especially in first six months to one year of diagnosis
Weaning to an extensively hydrolyzed casein formula is not associated with reduced incidence of type 1 diabetes among at-risk infants

No Reduced Risk of T1DM With Hydrolyzed Casein Infant Formula

No reduction in cumulative incidence of type 1 diabetes in infants at risk after 11.5-year follow-up
Dasiglucagon is well tolerated and is associated with an early pharmacodynamic response similar to that of GlucaGen for severe hypoglycemia

Dasiglucagon Well Tolerated for Severe Hypoglycemia

Early pharmacodynamic response similar to that of GlucaGen, with longer lasting effects plasma glucose
The cumulative risk of end-stage renal disease among patients with type 1 diabetes has declined over time in Finland

Risk of ESRD in T1DM Patients Has Fallen Markedly in Finland

Relative risk of end-stage renal disease was 0.13 in those diagnosed in 1995-2011 versus 1965-1979
Transcription factor 7 like 2 (TCF7L2) genetic variants contribute to phenotypic heterogeneity of type 1 diabetes

Genetic Variants Tied to Type 1 Diabetes Heterogeneity

TCF7L2 variants associated with single autoantibody, higher C-peptide, lower glucose
Oral insulin does not delay onset of type 1 diabetes in autoantibody-positive relatives of patients with type 1 diabetes

Insulin Doesn’t Prevent Diabetes in Relatives of T1DM Patients

Oral insulin doesn't delay onset in autoantibody-positive relatives of patients with type 1 diabetes
For patients with type 1 diabetes

Leisure Time Exercise Linked to Reduced Mortality in T1DM

Exercise also linked to lower mortality in patients with type 1 diabetes and chronic kidney disease
Among patients with childhood-onset type 1 diabetes

Risk of End-Stage Renal Disease Low With Type 1 Diabetes

Findings among a large study of Norwegian children followed for 40-plus years
A novel adaptive artificial pancreas can reduce hemoglobin A1c in adults with type 1 diabetes

Novel Artificial Pancreas Cuts HbA1c, Hypoglycemia in T1DM

Basal insulin delivery settings used by AP were adapted throughout the 12-week study
For adolescents with type 1 diabetes and high levels of albumin excretion

ACE Inhibitor, Statin No Benefit for T1DM, High Albumin Excretion

Use of ACE inhibitor and a statin does not change albumin-to-creatinine ratio in adolescents with T1DM